Pub. Date : 2006 Feb
PMID : 16583725
5 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | CACNA1A mutation in a EA-2 patient responsive to acetazolamide and valproic acid. | Acetazolamide | calcium voltage-gated channel subunit alpha1 A | Homo sapiens |
| 2 | CACNA1A mutation in a EA-2 patient responsive to acetazolamide and valproic acid. | Acetazolamide | calcium voltage-gated channel subunit alpha1 A | Homo sapiens |
| 3 | RESULTS: In this study we identified a new missense mutation in exon 12 of the CACNA1A gene from a patient with EA-2 whose symptoms could be controlled with a combination of acetazolamide and valproic acid. | Acetazolamide | calcium voltage-gated channel subunit alpha1 A | Homo sapiens |
| 4 | RESULTS: In this study we identified a new missense mutation in exon 12 of the CACNA1A gene from a patient with EA-2 whose symptoms could be controlled with a combination of acetazolamide and valproic acid. | Acetazolamide | calcium voltage-gated channel subunit alpha1 A | Homo sapiens |
| 5 | Here we describe a patient with a novel mutation in the CACNA1A gene who responded positively to a combination of acetazolamide and valproic acid. | Acetazolamide | calcium voltage-gated channel subunit alpha1 A | Homo sapiens |